Navigation Links
European Medicines Agency (EMEA) Recommends Herceptin For Early Stage Breast Cancer

The European Medicines Agency (EMEA) has recommended the use of breast cancer drug Herceptin in early stages of the cancer in a record 27 days review//. A license for the drug is to be issued in three months time.

The National Institute of Health and Clinical Excellence in the UK will decide now if Herceptin can be recommended in the NHS. The drug, which costs £20,000 a year, is already being fast tracked by NICE. "We will be able to issue national guidance to the NHS on the use of Herceptin within weeks of the drug being licensed for safety by the EMEA," said Andrew Dillon, NICE chief executive.

Herceptin is already licensed for use in advanced breast cancer. But some trials showed that it is useful in early stages as well and the UK has seen a number of women drag NHS trusts to court over refusal to fund the drug. Health Secretary Patricia Hewitt had said last October that NHS bodies must not refuse the drug, if the doctors had recommended it.

But NHS trusts continued to refuse the drug, forcing patients to seek refuge in court. Ann Marie Rogers of Swindon, Wiltshire won a case earlier this month ruling forcing her local primary care trust to fund Herceptin. The news of Herceptin's approval by the EMEA was welcomed by charity Breakthrough Breast Cancer, "Not only does this confirm the drug's importance, it should also help reassure those who may have previously doubted its effectiveness and safety," said Chief executive Jeremy Hughes. "We hope that in light of today's decision, any PCT still wavering about prescribing Herceptin, should now have the confidence to make it available to all for whom it is recommended."


'"/>




Page: 1

Related medicine news :

1. Lung Cancer Deaths Declining In Men But Not Women In European Countries
2. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
3. European Countries To Fund $4 Billion For Vaccination For Poor Children’
4. Nanotechnology Revolution To Be Spearheaded By European Union
5. Detection of Weak strains of bird flu virus – Target of European Unio
6. Europe On High Bird Flu Alert: European Commission
7. Slovenia, Bulgaria, Greece Face Bird Flu Threat: European Union
8. Heart Brakes: Hearts in European Union Invite Health Attention
9. European Union: Poultry producers Need Aid to Survive Bird flu crisis
10. 5th European Breast Cancer Conference Talks about Everything from Patient to Oncologist
11. Control And Prevention Of Three Diseases To Be Discussed: European Commission
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... (PRWEB) , ... April 30, 2016 , ... Mercy College ... campus. The following programs will be expanding due to high demand: Master of ... The expansion will begin this summer. , School of Business Graduate Program ...
(Date:4/29/2016)... ... 29, 2016 , ... Our bodies are bombarded daily by environmental and lifestyle ... these stressors is to adopt a more healthful diet, but too many people think ... certified Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating ...
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... ... City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert in ... apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer from ... bones. This surgery is performed to correct the alignment of the jaw. It is beneficial ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Automation is one of the best ... growing demands for productivity in speed, accuracy, throughput and ... already adept of a wide range of functions that ... Instrumentation continues to evolve, and is poised to tackle ... years ago. Originally used mostly by the big pharmaceutical ...
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
Breaking Medicine Technology: